Cargando…

CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor

Circulating tumor cells (CTCs) and/or circulating tumor microemboli (CTM) from non-small cell lung cancer (NSCLC) patients may be a non-invasive tool for prognosis, acting as liquid biopsy. CTCs interact with platelets through the transforming growth factor-β/transforming growth factor-β receptor ty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torres, Jacqueline Aparecida, Brito, Angelo Borsarelli Carvalho, Silva, Virgilio Souza e, Messias, Iara Monique, Braun, Alexcia Camila, Ruano, Anna Paula Carreta, Buim, Marcilei E. C., Carraro, Dirce Maria, Chinen, Ludmilla Thomé Domingos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419161/ https://www.ncbi.nlm.nih.gov/pubmed/37569332 http://dx.doi.org/10.3390/ijms241511958

Ejemplares similares

A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer
por: Abdallah, Emne Ali, et al.
Publicado: (2020)

Baseline and Kinetic Circulating Tumor Cell Counts Are Prognostic Factors in a Prospective Study of Metastatic Colorectal Cancer
por: Silva, Virgílio Souza e, et al.
Publicado: (2021)

MIR-203A-3P AND MMP-2 PROTEINS ARE HIGHLY EXPRESSED IN CIRCULATING TUMOR CELLS FROM PATIENTS WITH PANCREATIC CARCINOMA
por: TARAZONA, José Gabriel Rodríguez, et al.
Publicado: (2022)

Comparison of hormonal receptor expression and HER2 status between circulating tumor cells and breast cancer metastases
por: Sanches, Solange Moraes, et al.
Publicado: (2021)

Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer()
por: Zheng, Xiumei, et al.
Publicado: (2017)

Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion
por: Chinen, Ludmilla T Domingos, et al.
Publicado: (2014)

Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma
por: Ruano, Anna Paula Carreta, et al.
Publicado: (2022)

Molecular and Dynamic Evaluation of Proteins Related to Resistance to Neoadjuvant Treatment with Chemoradiotherapy in Circulating Tumor Cells of Patients with Locally Advanced Rectal Cancer
por: Silva, Virgílio Souza e, et al.
Publicado: (2021)

Circulating Tumor Cells in Desmoid Tumors: New Perspectives
por: Braun, Alexcia C., et al.
Publicado: (2021)

Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients
por: Troncarelli Flores, Bianca C., et al.
Publicado: (2019)

Thymidylate synthase expression in circulating tumor cells: A new tool to predict 5‐fluorouracil resistance in metastatic colorectal cancer patients
por: Abdallah, Emne Ali, et al.
Publicado: (2015)

EVALUATING MMP-2 AND TGFß-RI EXPRESSION IN CIRCULATING TUMOR CELLS OF PANCREATIC CANCER PATIENTS AND THEIR CORRELATION WITH CLINICAL EVOLUTION
por: GASPARINI-JUNIOR, José Luiz, et al.
Publicado: (2019)

Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions
por: Mascalchi, Mario, et al.
Publicado: (2017)

Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells
por: Souza e Silva, Virgílio, et al.
Publicado: (2016)

New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma
por: Wan, Shanshan, et al.
Publicado: (2019)

Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells
por: Oliveira-Costa, Joao Paulo, et al.
Publicado: (2015)

Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer
por: Chen, Yang, et al.
Publicado: (2021)

EGFR/MET promotes hepatocellular carcinoma metastasis by stabilizing tumor cells and resisting to RTKs inhibitors in circulating tumor microemboli
por: Song, Shouyang, et al.
Publicado: (2022)

Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection
por: Chen, Jia-Yang, et al.
Publicado: (2016)

Heterogeneity of HER2 Expression in Circulating Tumor Cells of Patients with Breast Cancer Brain Metastases and Impact on Brain Disease Control
por: de Castro, Douglas Guedes, et al.
Publicado: (2022)

Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy
por: Zhang, Dejun, et al.
Publicado: (2017)

Prospective Assessment of the Association Between Circulating Tumor Cells and Control of Brain Disease After Focal Radiation Therapy of Breast Cancer Brain Metastases
por: Guedes de Castro, Douglas, et al.
Publicado: (2021)

Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients
por: Silvestri, Marco, et al.
Publicado: (2021)

Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9
por: Chu, Hsueh-Yao, et al.
Publicado: (2021)

High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness
por: Long, Elodie, et al.
Publicado: (2016)

Oesophagus cancer, secondary cardiac tumour, and pulmonary microemboli
por: Tanaka, Yutaka, et al.
Publicado: (2022)

Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells
por: Lian, Shu, et al.
Publicado: (2019)

CIRCULATING TUMOR CELLS
por: Paiva, Bruno
Publicado: (2022)

Application of circulating tumor cells scope technique on circulating tumor cell research
por: Yang, Dawei, et al.
Publicado: (2014)

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma
por: Beasley, Aaron, et al.
Publicado: (2018)

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring
por: ALEMZADEH, EFFAT, et al.
Publicado: (2023)

Tumor Hypoxia and Circulating Tumor Cells
por: Tinganelli, Walter, et al.
Publicado: (2020)

Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer
por: Gao, Yang, et al.
Publicado: (2016)

Role of circulating tumor DNA and circulating tumor cells in breast cancer: History and updates
por: Chedid, Julien, et al.
Publicado: (2022)

Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers
por: Addanki, Sridevi, et al.
Publicado: (2022)

Microemboli-monitoring during the acute phase of ischemic stroke: Is it worth the time?
por: Idicula, Titto T, et al.
Publicado: (2010)

Detection of Circulating Tumor Cells
por: de Wit, Sanne, et al.
Publicado: (2014)

Metastasis and Circulating Tumor Cells
por: van Dalum, Guus, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j4ef2hfkspjmp7tajo1l88rctj